Related Experiment Videos

Association of cardiometabolic risk factors and prevalent cardiovascular events

Dan C Malone1, Denise M Boudreau, Greg A Nichols

  • 1College of Pharmacy, University of Arizona, Tucson, Arizona 85721-0202, USA. malone@pharmacy.arizona.edu

Insights

The number of cardiometabolic risk factors directly correlates with increased risk of acute myocardial infarction (AMI) and stroke. Diabetes, hypertension, and dyslipidemia pose the highest combined risk.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Cardiovascular disease (CVD) poses significant health risks, yet the cumulative impact of risk factors on outcomes like acute myocardial infarction (AMI) and stroke is not fully understood.
  • This research investigates the association between various cardiometabolic risk factors and the prevalence of AMI and stroke diagnoses.

Purpose of the Study:

  • To evaluate the relationship between the number of cardiometabolic risk factors and the likelihood of prevalent acute myocardial infarction (AMI) and stroke.
  • To identify combinations of risk factors that confer the highest risk for these cardiovascular events.

Main Methods:

  • Retrospective analysis of data from 170,648 adult enrollees across three integrated health-care systems (July 2003 - June 2005).
  • Inclusion criteria required measurements for weight, height, blood pressure, HDL, triglycerides, and fasting glucose or diabetes status.
  • Cardiometabolic risk factors were defined using National Cholesterol Education Program Adult Treatment Panel III guidelines.

Main Results:

  • A dose-response relationship was observed: individuals with more risk factors had a significantly higher likelihood of AMI or stroke.
  • Compared to those with no risk factors, individuals with 1, 2, 3, 4, or 5 risk factors showed increased odds ratios of 2.21, 2.79, 3.45, 4.35, and 5.73, respectively.
  • The combination of diabetes, hypertension, and dyslipidemia, with or without obesity, presented the highest risk for cardiovascular events.

Conclusions:

  • An increasing number of cardiometabolic risk factors is directly associated with a higher prevalence of acute myocardial infarction (AMI) and stroke.
  • Diabetes, hypertension, and dyslipidemia represent a critical cluster of risk factors, significantly elevating the risk for cardiovascular events.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...